Amedica Corporation has announced several new additions to its executive management team to promote its proprietary Silicon Nitride (Si3N4) ceramic.
According to a company press release, four strategic appointments—a senior vice president of market development, vice president of marketing, a senior vice president of sales, and a chief legal and compliance officer—have been added to the executive team.
Vytas Rupinskas joins Amedica as vice Ppresident of marketing; Paul Sendro, formerly senior vice president of sales for Amedica, will now be leading the company’s strategic market development initiatives; Jim Abraham joins Amedica as senior vice president of sales; and Kevin Ontiveros joins Amedica as chief legal and compliance officer
“This is a momentous time for us as we expand our leadership team and gain extensive expertise and insights to further execute on our business strategy. Mr Rupinskas, Mr Sendro, Mr Abraham, and Mr Ontiveros bring a wealth of experience to Amedica that will be critical to our ongoing success,” said Eric K Olson, president and chief executive officer, Amedica.
The press released stated that Amedica is focused on advancing medical applications of its proprietary silicon nitride ceramic. In November 2007, the company secured clearance from the FDA to manufacture and market silicon nitride-based interbody fusion devices. The resulting Valeo product line was launched in 2008 and has since been adopted by physicians across the country as the premier interbody fusion device, the press release added. In September 2012, Amedica announced the expansion of biomaterial claims for its FDA 510(k) cleared Valeo interbody fusion devices. In recent studies published in peer-reviewed journals, silicon nitride demonstrated anti-infective properties as well as superior new bone formation and osteointegration in comparison to PEEK and titanium. Also in September of 2012, Amedica received 510(k) clearance from the FDA to market a second generation family of cervical and lumbar interbody fusion devices. The company is also exploring innovative solutions for orthopaedic implants.
